Medical affairs and commercial teams have organized around key opinion leaders for decades, and for good reason: the experts who run pivotal trials and write treatment guidelines shape clinical practice for years. But a growing share of scientific influence now plays out somewhere else entirely, on X, LinkedIn, YouTube, podcasts, and open online communities. It is often driven by voices who never appear on a traditional KOL list. Analyses of major oncology congresses show that discussion of new data on social platforms has grown steadily for over a decade, with interpretation of headline results forming online during the meeting itself rather than after publication [1, 2]. Teams that only watch traditional channels see that shift late.
This article lays out what separates a KOL from a DOL, where the two overlap, and what that means for how life sciences teams build their engagement strategy.
What is a KOL (Key Opinion Leader)?
A key opinion leader (KOL) is a physician, researcher, or other healthcare expert whose credentials and body of work give them outsized influence over how their peers think and practice. That influence is built through the traditional machinery of scientific authority: peer-reviewed publications, clinical trial leadership, guideline committee membership, podium presentations at major congresses, and senior roles at academic medical centers and professional societies.
KOL influence tends to be deep and institutional. A single KOL may shape guidelines that direct treatment decisions for years, lead the registrational trials behind a new therapy, or train a generation of specialists in their field. That influence builds slowly, and it lasts.
What is a DOL (Digital Opinion Leader)?
A digital opinion leader (DOL) is a healthcare voice whose influence operates primarily through digital and social channels: X, LinkedIn, YouTube, podcasts, blogs, and online medical communities. Peer-reviewed research characterizes DOLs as healthcare professionals with substantial online followings who play a central role in disseminating health information and countering misinformation [3]. What distinguishes a DOL from a merely active account is impact on peers rather than volume of posting.
DOL influence tends to be fast and broad. When results drop at a major congress, DOLs are often the first to summarize, contextualize, and critique them, reaching audiences in the tens of thousands before formal literature responds. An analysis of breast cancer oncologists' social media activity across 2024 found that their online conversation spiked around major congresses including ESMO, ASCO, and the San Antonio Breast Cancer Symposium, with DOLs sharing live updates and trial summaries that attracted tens of thousands of views per post [4]. Many DOLs are practicing clinicians; others are researchers, pharmacists, patient advocates, or medical educators.
KOL vs. DOL: the key differences
KOL
DOL
Primary channels
Publications, congresses, guidelines, advisory boards
Social media, podcasts, video, online communities
Nature of influence
Deep, institutional, slow-building
Fast, broad, conversational
Typical audience
Peer specialists, institutions
Clinicians, trainees, patients, public
How influence is measured
Publication and citation record, trial leadership, guideline roles
Reach, engagement, share of voice, network position
Speed of impact
Months to years
Hours to days
Frequently Asked Questions
Is a DOL the same as an influencer?
Not quite. “Influencer” usually implies consumer marketing. A DOL is defined by scientific or clinical influence exercised through digital channels. The audience is often other healthcare professionals, and the content is scientific exchange rather than promotion.
Can someone be both a KOL and a DOL?
Yes, and hybrid experts are often the most strategically valuable stakeholders: they carry institutional authority into fast-moving digital conversations. Influence maps should treat KOL and DOL as attributes of a person, not exclusive categories.
How is DOL influence measured?
Meaningful measurement combines reach (audience size), engagement (who responds and shares), relevance (topical focus), and network position (amplification by other experts) — tracked over time, because digital influence shifts quickly.
Why do medical affairs teams track DOLs?
Because scientific sentiment now forms in digital channels first. At major congresses, interpretation of new data often crystallizes on social platforms within hours — before formal publication [1, 5]. Teams that only monitor traditional channels see that shift late.
